Dry Age-Related Macular Degeneration AMD Market Trends

Key Emerging Trends in the Dry Age-Related Macular Degeneration AMD Market

Dry Age-related Macular Degeneration (AMD) stands as one of the prevalent eye conditions among individuals aged 60 and above. Its correlation with advancing age makes it a progressively worsening ailment. Over time, this condition leads to the thinning and eventual degeneration of the light-sensitive cells in the macula, contributing to vision impairment. The United Nations (UN) shed light on a significant trend in their December 2020 report, revealing a rapid increase in the world's older population. This surge is attributed to rising life expectancies coupled with declining fertility rates. As of 2020, the report highlighted that 727 million individuals aged 65 or older were living globally, projecting a substantial increase to approximately 1.5 billion by 2050. This growth signifies a considerable demographic shift, where the proportion of the global population aged 65 or above is anticipated to rise from 9.3% in 2020 to around 16.0% by 2050.

This demographic trend mirrors a similar pattern observed in China. The UN's projections for China indicate a notable surge in the proportion of adults aged over 65. In 2020, this demographic accounted for 12% of the population, a figure expected to double to 26% by 2050. This significant increase in the elderly population poses implications for health care systems, particularly in addressing age-related ailments like Dry AMD. As this eye disorder is closely linked to aging, the burgeoning elderly population globally, including in China, underscores the pressing need for effective treatments and healthcare interventions to mitigate the impact of vision-related conditions on the aging population.

The statistics revealed by the UN report paint a compelling picture of the demographic shifts underway worldwide. The substantial increase in the elderly population, coupled with the direct association of Dry AMD with advancing age, emphasizes the criticality of proactive measures in healthcare and research. Addressing the growing prevalence of age-related eye disorders necessitates a proactive approach in developing innovative treatments, enhancing healthcare accessibility, and implementing preventative strategies to ensure a better quality of life for the aging population globally, safeguarding their visual health amidst the demographic transformations taking place.